Global Insulin Glargine Market Size, Growth, Forecasts to 2033

The Global Insulin Glargine Market Size is Anticipated to Exceed USD 2.50 Billion by 2033, Growing at a CAGR of 6.12% from 2023 to 2033. Insulin glargine is a synthetic form of human insulin approved by the FDA for the treatment of type 1 diabetes in adults and children, as well as type 2 diabetes in adults, to enhance and maintain glycemic control.